Get the Stockscreener App
6.46
3.44%
-0.23
After Hours:
6.46
Cvrx Inc stock is traded at $6.46, with a volume of 193.44K.
It is down -3.44% in the last 24 hours and down -17.07% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$6.69
Open:
$6.7
24h Volume:
193.44K
Relative Volume:
0.51
Market Cap:
$168.41M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-2.3883
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
-5.00%
1M Performance:
-17.07%
6M Performance:
-51.79%
1Y Performance:
-25.66%
1-Day Range:
$6.45
$6.7972
1-Week Range:
$6.20
$6.95
52-Week Range:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
6.46 | 177.29M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
133.94 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.83 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.10 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.00 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
CVRx Confirms Directors and Accounting Firm at Meeting - TipRanks
CVRx at William Blair Conference: Strategic Focus on Barostim - Investing.com
CVRx at William Blair Conference: Strategic Focus on Barostim By Investing.com - Investing.com UK
Nuveen Asset Management LLC Has $2.01 Million Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Learn to Evaluate (CVRX) using the Charts - news.stocktradersdaily.com
Millennium Management LLC Sells 30,168 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx to Present at the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Medical Device Leader CVRx Showcases Cardiovascular Breakthroughs at Major Growth Conference - Stock Titan
CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by Northern Trust Corp - Defense World
D. E. Shaw & Co. Inc. Cuts Stock Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
47,120 Shares in CVRx, Inc. (NASDAQ:CVRX) Purchased by BNP Paribas Financial Markets - Defense World
Long Term Trading Analysis for (CVRX) - news.stocktradersdaily.com
Monday 5/19 Insider Buying Report: HUM, CVRX - Nasdaq
Director Makes Bold Move with Massive CVRx Stock Purchase - TipRanks
CVRx Poised for Growth: Buy Rating Affirmed Amid Sales Restructuring and Potential Reimbursement Catalyst - TipRanks
Insider Buying: Kevin Hykes Acquires Additional Shares of CVRx I - GuruFocus
CVRx CEO Makes Bold Investment Move! - TipRanks
Wells Fargo & Company MN Has $113,000 Holdings in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Barclays PLC Boosts Stake in CVRx, Inc. (NASDAQ:CVRX) - Defense World
(CVRX) Trading Advice - news.stocktradersdaily.com
Piper Sandler Has Lowered Expectations for CVRx (NASDAQ:CVRX) Stock Price - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
CVRx Reports First Quarter 2025 Financial and Operating Results - ADVFN
CVRx, Inc. (NASDAQ:CVRX) Q1 2025 Earnings Call Transcript - Insider Monkey
JPMorgan cuts CVRx stock rating, slashes price target to $7 By Investing.com - Investing.com India
CVRx (CVRX) Sees Downgrade and Price Target Reduction from JP Mo - GuruFocus
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates - MSN
CVRx Earnings Call: Growth Amidst Challenges - TipRanks
CVRx (CVRX) Shares Fall Following Q1 Sales Miss and Downgrade - GuruFocus
CVRx price target lowered to $12 from $20 at Piper Sandler - TipRanks
JPMorgan cuts CVRx stock rating, slashes price target to $7 - Investing.com
CVRx stock downgraded at J.P. Morgan on Q1 miss (CVRX:NASDAQ) - Seeking Alpha
Demystifying CVRx: Insights From 4 Analyst Reviews - Benzinga
CVRx (CVRX) Target Price Lowered by Piper Sandler | CVRX Stock N - GuruFocus
Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and CVRx (CVRX) - The Globe and Mail
Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25% - simplywall.st
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15 - marketscreener.com
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
CVRx Q1 2025 revenue increases 15% to USD 12.3 million - Medical Buyer
CVRx: Q1 Earnings Snapshot - San Francisco Chronicle
CVRx downgraded to Underweight from Neutral at JPMorgan - TipRanks
CVRx Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CVRx Q1 2025 shows improved EPS, stock dips - Investing.com Nigeria
CVRx Inc (CVRX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Sales Force Realignment ... By GuruFocus - Investing.com Canada
CVRx Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvrx Inc Stock (CVRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
| Jain Mudit K. | Director |
May 13 '25 |
Buy |
5.26 |
150 |
789 |
5,050 |
| Hykes Kevin | PRES & CEO |
May 12 '25 |
Buy |
4.84 |
5,000 |
24,200 |
133,000 |
0.64%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):